Psychotherapeutic Control of Hypertension

scientific article published on 01 January 1976

Psychotherapeutic Control of Hypertension is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1056/NEJM197601082940204
P953full work available at URLhttp://www.nejm.org/doi/pdf/10.1056/NEJM197601082940204
P698PubMed publication ID1244504

P2093author name stringR. A. Stone
J. DeLeo
P2860cites workMolecular PharmacologyQ1943386
Human Serum Dopamine-β-Hydroxylase: Relationship to Hypertension and Sympathetic ActivityQ22241924
Neurally mediated increase in dopamine-beta-hydroxylase activityQ33696909
Physiological Effects of Transcendental MeditationQ34233188
Effects of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man.Q34463968
Measurement of human dopamine-beta-hydroxylase in serum by homologous radioimmunoassayQ35071215
12-month follow-up of yoga and bio-feedback in the management of hypertensionQ39313012
Randomised controlled trial of yoga and bio-feedback in management of hypertensionQ39334050
Serum dopamine β-hydroxylase as an index of sympathetic functionQ39943245
Serum Dopamine-Beta-Hydroxylase ActivityQ43488961
Effect of Psychosocial Stimulation on the Enzymes Involved in the Biosynthesis and Metabolism of Noradrenaline and AdrenalineQ43935290
A model of psychosocial hypertension showing reversibility and progression of cardiovascular complicationsQ44809879
Federation ProceedingsQ45106928
Decreased blood-pressure in pharmacologically treated hypertensive patients who regularly elicited the relaxation response.Q48579542
Learned control of blood pressure in patients with high blood pressureQ52313761
Serum dopamine-beta-hydroxylase during development of immobilization-induced hypertension.Q53726943
Release of Dopamine-β-hydroxylase with Norepinephrine during Cat Splenic Nerve StimulationQ59074331
Plasma dopamine-beta-hydroxylase activity in oral contraceptive hypertensionQ66918680
Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjectsQ68602093
Radioimmunoassay and clearance of circulating dopamine- -hydroxylaseQ68647269
Neurogenic factors in human hypertension: mechanism or myth?Q68669673
Changes of plasma dopamine-beta-hydroxylase activity and other plasma constituents during the cold pressor testQ68776862
Relationship between serum dopamine-beta-hydroxylase activity, catecholamine metabolism, and hemodynamic changes during paroxysmal hypertension in quadriplegiaQ68828908
On the fate of dopamine-beta-hydroxylase after release from the pheripheral sympathetic nerves in the catQ68885774
Lesch-Nyhan Syndrome: Evidence for Abnormal Adrenergic FunctionQ68920329
Plasma Norepinephrine Levels in Essential HypertensionQ69479806
Plasma dopamine beta-hydroxylase: a possible aid in the study and evaluation of hypertensionQ69731330
Decreased blood pressure in borderline hypertensive subjects who practiced meditationQ69769774
P433issue2
P407language of work or nameEnglishQ1860
P921main subjecthypertensionQ95566669
P304page(s)80-84
P577publication date1976-01-01
1976-01-08
P1433published inThe New England Journal of MedicineQ582728
P1476titlePsychotherapeutic control of hypertension
Psychotherapeutic Control of Hypertension
P478volume294

Reverse relations

cites work (P2860)
Q34195144A Relaxation Technique In the Management of Hypercholesterolemia
Q35014701A systematic review of neurobiological and clinical features of mindfulness meditations.
Q30539248Acquisition, discriminative stimulus control, and retention of increases/decreases in blood pressure of normotensive human subjects
Q40832664Behavioral Approaches to the Treatment of Hypertension
Q38502554Behavioral medicine approaches to hypertension: An integrative analysis of theory and research
Q45424230Biochemical changes associated with thermal biofeedback treatment of hypertension
Q40782975Biofeedback Training for Cardiovascular Dysfunctions
Q40022431Biofeedback and relaxation in blacks with hypertension: a preliminary study
Q39813087Biofeedback and relaxation training in the treatment of psychophysiological disorders: Or are the machines really necessary?
Q68577612Biofeedback treatments of essential hypertension
Q40787119Biofeedback-aided relaxation and meditation in the management of hypertension
Q39853041Blood Pressure and Hypertension in Childhood and Adolescence
Q40283078Blood pressure and primary hypertension in childhood and adolescence
Q34109490Blood pressure in infants children and adolescents
Q41036882Blood pressure, heart rate and respiratory responses to a single session of relaxation: A partial replication
Q66883749Daily relaxation response breaks in a working population: I. Effects on self-reported measures of health, performance, and well-being
Q66883751Daily relaxation response breaks in a working population: II. Effects on blood pressure
Q40900890Decreased [Vdot]O2Consumption during Exercise with Elicitation of the Relaxation Response
Q67487304Editorial:Meditation or methyldopa?
Q30440673Goiter in Tibetan medicine
Q47650185Health Education: Can the Reformers Be Reformed?
Q40975920Hypertension self-control with a portable feedback unit or meditation-relaxation
Q40748306Hypertension: Medicate or meditate?
Q39511913Inability to demonstrate physiologic correlates of subjective improvement among patients taught the relaxation response.
Q66703687Letter: Injecting the painful shoulder
Q66703688Letter: TM and hypertension
Q39413193Limitations of transcendental meditation in the treatment of essential hypertension
Q37285593Meditation and psychiatry
Q34333422Meditation from a mental health prospective.
Q72145168Meditation training and essential hypertension: a methodological study
Q37171284Neurochemistry and Child Psychiatry
Q40994997New approaches to the management of essential hypertension with psychological techniques
Q39795192Nonpharmacologic therapy for hypertension
Q39344458Physiological responses during meditation and rest
Q70246425Prazosin depression of baroreflex function in hypertensive man
Q70397264Propranolol effects on autonomic function in hypertensive men
Q39633340Psychological methods in treatment of hypertension: a review
Q41302526Relationship between avoidance-induced arousal and plasma DBH, glucose and renin activity
Q24242620Relaxation therapies for the management of primary hypertension in adults
Q37189310Relaxation therapies for the management of primary hypertension in adults: a Cochrane review.
Q41206522Relaxation therapy for essential hypertension: A veterans administration outpatient study
Q41002848Self-control progressive relaxation training as an alternative nonpharmacological treatment for essential hypertension: therapeutic effects in the natural environment
Q39276519Setting generality of blood pressure reductions and the psychological treatment of reactive hypertension
Q37777716Stress management for athletes
Q70283664Stress management training and relaxation imagery in the treatment of essential hypertension
Q40767532Systemic Hypertension and the Relaxation Response
Q40499839The Prevention of Hypertension
Q40782979The Relaxation Response: A Bridge Between Psychiatry and Medicine
Q70577365The combined effect of prazosin and autogenic training on cold reactivity in Raynaud's phenomenon
Q70212645The effect of biofeedback-assisted relaxation training on blood pressure and selected biochemical parameters in patients with essential hypertension
Q39167539The efficacy of progressive relaxation in systematic desensitization and a proposal for an alternative competitive response—the relaxation response
Q40129447The relation of social to biological processes in disease

Search more.